Skip to main content

Study Explores Persons With Tobacco Exposure, Preserved Spirometry

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Aug. 3, 2023 -- Persons with tobacco exposure and preserved spirometry (TEPS) with symptoms (symptomatic TEPS) do not have accelerated rates of decline in forced expiratory volume in one second (FEV1) or chronic obstructive pulmonary disease (COPD) versus those with asymptomatic TEPS, but they do have more respiratory exacerbations, according to a study published in the Aug. 1 issue of the Journal of the American Medical Association.

William McKleroy, M.D., from the University of California in San Francisco, and colleagues defined the natural history of symptomatic TEPS in an extension of the SPIROMICS I multicenter study of persons aged 40 to 80 years who smoked cigarettes, with or without COPD, and controls without tobacco exposure or airflow obstruction. Data were included for 1,397 study participants: 226 with symptomatic TEPs and 269 with asymptomatic TEPS.

The researchers found that at a median follow-up of 5.76 years, the decline in FEV1 was −31.3 and −38.8 mL/y for participants with symptomatic and asymptomatic TEPS, respectively. The cumulative incidence of COPD was 33.0 and 31.6 percent for those with symptomatic and asymptomatic TEPS, respectively. Significantly more respiratory exacerbations were seen for participants with symptomatic versus asymptomatic TEPS (0.23 versus 0.08 exacerbations per person-year; rate ratio, 2.38).

"We found that many people who have a lot of primary tobacco exposure have the same symptoms as people who have COPD, but can't be diagnosed with COPD, because their FEV1/forced vital capacity ratio is considered normal on spirometry," McKleroy said in a statement. "This demonstrates a major gap in effective and compassionate care for tobacco-exposed persons."

Several authors disclosed ties to the biopharmaceutical industry; support for the study was provided by several biopharmaceutical companies.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Parental E-Cigarette Use Linked to Increase in Pediatric Atopic Dermatitis

TUESDAY, May 28, 2024 -- Parental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online...

E-Cigarette Use After Smoking May Up Risk for Lung Cancer

WEDNESDAY, May 22, 2024 -- Former cigarette smokers who use electronic cigarettes may have a higher risk for lung cancer than those who do not vape, according to a study presented...

Use of Electronic Cigarettes Tied to Earlier Age at Onset of Adult Asthma

FRIDAY, May 17, 2024 -- Past 30-day electronic nicotine delivery systems (ENDS) use among adults is associated with earlier ages of asthma onset, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.